Kenya Launches Long-Acting HIV Prevention Drug Lenacapavir

Kenya Launches Long-Acting HIV Prevention Drug Lenacapavir

Nairobi -- Kenya has officially launched Lenacapavir, a groundbreaking long-acting injectable for HIV prevention, marking a major step in strengthening the country's response to the epidemic.

Kenya administers first HIV prevention shots

Kenya began administering the first dose of a groundbreaking HIV prevention drug in a Nairobi slum on Thursday. Lenacapavir, taken twice a year, has been shown to reduce the risk of HIV transmission by more than 99.9 percent, though it is technically a chemical drug rather than a vaccine because it does not train the immune system. A clinician administers a dose of the long-acting injectable HIV pre-exposure prophylaxis (PrEP), Lenacapavir inje…